Both in adolescents and adults, non-alcoholic steatohepatitis (NASH), the predominant manifestation of the metabolic syndrome in the liver, has become the most frequent cause of liver disease.1, 2 The mechanisms that contribute to liver injury in the setting of hepatic steatosis and insulin resistance remain obscure. This evidence concerns the gene INS and liver disorder.